Pricing Log in Create free account

Armata Pharmaceuticals, Inc. (ARMP) vs Genelux Corporation (GNLX)

Armata Pharmaceuticals, Inc. and Genelux Corporation are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Genelux Corporation are of similar size ($114.9M and $112.2M). Genelux Corporation has the higher net margin (0.00% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 15 metrics below, Genelux Corporation leads on 10 and Armata Pharmaceuticals, Inc. on 5.

Valuation

Metric ARMP GNLX Biotechnology median
P/E n/m n/m 8.50
P/S 22.01 9.67 9.71
P/B n/m 6.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 68.84 8.77 9.21
Earnings yield (159.94%) (35.54%) (33.15%)
Free cash flow yield (21.14%) (26.36%) (25.50%)

Profitability

Metric ARMP GNLX Biotechnology median
Gross margin 100.00% (3.42%) 65.16%
Operating margin (734.19%) 0.00% 0.00%
Net margin (3,467.04%) 0.00% 0.00%
Free cash flow margin (465.34%) 0.00% 0.00%
Return on equity 127.83% (177.93%) (56.36%)
Return on assets (225.11%) (121.80%) (48.04%)
Return on invested capital (89.61%) 0.00% 0.00%

Growth

Metric ARMP GNLX Biotechnology median
Revenue growth (TTM) (19.29%) — 6.02%
EPS growth (last fiscal year) (1,398.60%) 9.47% 30.26%
Revenue growth, 5-year CAGR 42.90% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARMP GNLX Biotechnology median
Debt to equity (1.23) 0.00 0.00
Current ratio 0.11 2.39 4.72
Net debt to EBITDA (7.07) 0.44 0.96

Dividend

Metric ARMP GNLX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARMP GNLX Biotechnology median
Market cap 114.90m 112.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack